User profiles for S Sánchez-Ramón

Silvia Sanchez-Ramon, MD, PhD

Inmunóloga clínica, Profesor Asociado de Inmunología, Hospital Clínico San Carlos …
Verified email at salud.madrid.org
Cited by 7211

Interleucinas en la fisiopatología de la artritis reumatoide: más allá de las citocinas proinflamatorias

S Sánchez-Ramón, FJ López-Longo, L Carreno - Reumatología clínica, 2011 - Elsevier
La artritis reumatoide (AR) es una enfermedad autoinmunitaria sistémica caracterizada por
sinovitis y destrucción progresiva del cartílago articular y hueso subyacente, junto con …

IVIg promote cross-tolerance against inflammatory stimuli in vitro and in vivo

…, J Ochoa-Grullón, S Sánchez-Ramón… - The Journal of …, 2018 - journals.aai.org
IVIg is an approved therapy for immunodeficiency and for several autoimmune and inflammatory
diseases. However, the molecular basis for the IVIg anti-inflammatory activity remains to …

[HTML][HTML] Coronavirus disease 2019 in patients with inborn errors of immunity: an international study

…, K Guevara-Hoyer, S Sánchez-Ramón… - Journal of Allergy and …, 2021 - Elsevier
Background There is uncertainty about the impact of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection in individuals with rare inborn errors of immunity (IEI), a …

Modelos de riesgo para la predicción de mortalidad hospitalaria en ancianos con neumonía por COVID-19

…, CA Urbina Carrera, S Sánchez Ramón… - 2021 - uvadoc.uva.es
… En primer lugar, se seleccionaron las variables que individualmente mostraron las
diferencias estadísticamente más significativas entre los grupos de supervivientes (S) y no …

The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression

…, R Samaniego, S Sánchez-Ramón… - Blood, the Journal of …, 2011 - ashpublications.org
Monocytes are versatile cells that can express different functional programs in response to
microenvironmental signals. We show that primary blood monocytes secrete the CXCL12 …

Association between anti–cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

…, S SánchezRamón… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular
disease that may not always be related to the presence of traditional cardiovascular risk factors…

[HTML][HTML] Trained immunity-based vaccines: a new paradigm for the development of broad-spectrum anti-infectious formulations

S Sánchez-Ramón, L Conejero, MG Netea… - Frontiers in …, 2018 - frontiersin.org
… Tejera-Alhambra M, Palomares O, Perez de Diego R, Diaz-Lezcano I, Sanchez-Ramon S.
New biological insights in the immunomodulatory effects of mucosal polybacterial vaccines in …

Memory B cells in common variable immunodeficiency: clinical associations and sex differences

S Sánchez-Ramón, L Radigan, EY Joyce, S Bard… - Clinical …, 2008 - Elsevier
Common variable immunodeficiency (CVID) is a heterogeneous syndrome characterized by
impaired antibody responses, recurrent infections, inflammatory, autoimmune and …

[HTML][HTML] Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity

…, JL Unzueta-Roch, S Sánchez-Ramón… - The Journal of …, 2014 - Am Soc Clin Investig
Heterotrimers composed of B cell CLL/lymphoma 10 (BCL10), mucosa-associated lymphoid
tissue lymphoma translocation protein 1 (MALT1), and caspase recruitment domain–…

Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing− remitting multiple sclerosis

…, E Fernández-Cruz, S Sánchez-Ramón - Journal of …, 2007 - Elsevier
Interferon beta-1a (IFNâ-1a) has demonstrated efficacy in multiple sclerosis (MS), although
its mechanism of action remains only partly understood. We evaluated the ex vivo and in vitro …